z-logo
open-access-imgOpen Access
Rescue of Cardiomyopathy in Peroxisome Proliferator-Activated Receptor-α Transgenic Mice by Deletion of Lipoprotein Lipase Identifies Sources of Cardiac Lipids and Peroxisome Proliferator-Activated Receptor-α Activators
Author(s) -
Jennifer G. Duncan,
Kalyani G. Bharadwaj,
Juliet L. Fong,
Riddhi Mitra,
Nandakumar Sambandam,
Michael Courtois,
Kory J. Lavine,
Ira J. Goldberg,
Daniel P. Kelly
Publication year - 2010
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.888735
Subject(s) - endocrinology , medicine , lipoprotein lipase , adipose triglyceride lipase , peroxisome proliferator activated receptor , peroxisome proliferator activated receptor alpha , cardiomyopathy , biology , receptor , chemistry , adipose tissue , heart failure , triglyceride , nuclear receptor , biochemistry , cholesterol , gene , transcription factor
Emerging evidence in obesity and diabetes mellitus demonstrates that excessive myocardial fatty acid uptake and oxidation contribute to cardiac dysfunction. Transgenic mice with cardiac-specific overexpression of the fatty acid-activated nuclear receptor peroxisome proliferator-activated receptor-alpha (myosin heavy chain [MHC]-PPARalpha mice) exhibit phenotypic features of the diabetic heart, which are rescued by deletion of CD36, a fatty acid transporter, despite persistent activation of PPARalpha gene targets involved in fatty acid oxidation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom